search
Back to results

The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation

Primary Purpose

Atrial Fibrillation

Status
Completed
Phase
Phase 4
Locations
United Kingdom
Study Type
Interventional
Intervention
ablation
RF ablation
Sponsored by
Oxford University Hospitals NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atrial Fibrillation focused on measuring atrial fibrillation, ablation, contact

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Participant is undergoing de novo pulmonary vein isolation procedure.
  2. Participant is willing and able to give informed consent for participation in the study.
  3. Male or Female, ≥18 years of age.

Exclusion Criteria:

  1. Previous percutaneous or open surgical procedure involving the left atrium
  2. Pregnancy (current or currently planning)

Sites / Locations

  • John Radcliffe Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Contact ECI active

Contact information deactivated

Arm Description

Contact ECI active

RF ablation without contact data

Outcomes

Primary Outcome Measures

The primary outcome measure will be the proportion (%) of pulmonary vein pairs found to be reconnected electrically to the left atrium at a subsequent redo ablation procedure

Secondary Outcome Measures

Proportion of acute venous electrical reconnections
proportion of pulmonary veins found to be electrically reconnected to the left atrium at the end of the index procedure
touch-up ablation requirements
proportion of veins requiring additional ablation after initial successful isolation, at the end of the index procedure
procedure time
duration of procedure
RF time
total amount of radiofrequency ablation required
anatomical location of reconnections at repeat procedure
anatomical location of electrical reconnections in pulmonary vein antra, as measured at a repeat ablation procedure
amount of RF required to achieve re-isolation at repeat ablation procedure
total time of RF delivery required to re-isolate the reconnected pulmonary veins at a repeat ablation procedure
complications
procedure-related complications

Full Information

First Posted
June 25, 2012
Last Updated
October 11, 2017
Sponsor
Oxford University Hospitals NHS Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT01629056
Brief Title
The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation
Official Title
The Contact-PVI Study - Does Assessment of Tissue Contact During RF Ablation Using the St. Jude Medical™ Ensite™ Contact™ System Increase Rates of Long-term Pulmonary Vein Isolation? A Prospective Randomised Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
February 3, 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Oxford University Hospitals NHS Trust

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to investigate the benefit of a new impedance-based computer software application during routine catheter ablation for atrial fibrillation, to see if this information improves short and long term electrical disconnection of the pulmonary veins. This study will be a single blind prospective randomised control trial in patients undergoing AF ablation. Study participants will be randomly assigned to undergo parts of their pulmonary vein ablation with, and parts of their ablation without tissue contact data displayed for the doctor performing the ablation to see. The pulmonary veins will then be studied at the end of the procedure, and at any repeat procedure in the future, to look for a difference in the recovery rate of the ablations performed using contact data, compared to those ablations performed without the use of this contact data. If a reduction in tissue recovery is achieved through the use of this tissue contact data, it may lead in the future to a reduced need for repeat ablation procedures, and better outcomes for patients. The investigators hypothesise that the use of the Ensite™ Contact™ ECI data will reduce the recovery of conduction, and promote long-term pulmonary vein isolation in patients undergoing left atrial ablation for atrial fibrillation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation
Keywords
atrial fibrillation, ablation, contact

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
148 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Contact ECI active
Arm Type
Active Comparator
Arm Description
Contact ECI active
Arm Title
Contact information deactivated
Arm Type
Placebo Comparator
Arm Description
RF ablation without contact data
Intervention Type
Procedure
Intervention Name(s)
ablation
Other Intervention Name(s)
Irrigated RF ablation, RF ablation, Percutaneous transvenous catheter ablation
Intervention Description
RF ablation to the left atrium of the heart, guided by ECI-contact information (active arm)
Intervention Type
Procedure
Intervention Name(s)
RF ablation
Other Intervention Name(s)
Irrigated RF ablation, Percutaneous transvenous catheter ablation
Intervention Description
RF ablation to the left atrium of the heart, without the use of ECI-contact information (control arm)
Primary Outcome Measure Information:
Title
The primary outcome measure will be the proportion (%) of pulmonary vein pairs found to be reconnected electrically to the left atrium at a subsequent redo ablation procedure
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Proportion of acute venous electrical reconnections
Description
proportion of pulmonary veins found to be electrically reconnected to the left atrium at the end of the index procedure
Time Frame
acute (intra-procedure)
Title
touch-up ablation requirements
Description
proportion of veins requiring additional ablation after initial successful isolation, at the end of the index procedure
Time Frame
acute (intra-procedure)
Title
procedure time
Description
duration of procedure
Time Frame
acute
Title
RF time
Description
total amount of radiofrequency ablation required
Time Frame
acute (intra-procedure)
Title
anatomical location of reconnections at repeat procedure
Description
anatomical location of electrical reconnections in pulmonary vein antra, as measured at a repeat ablation procedure
Time Frame
at repeat ablation procerdure (6-12 months post index ablation procedure)
Title
amount of RF required to achieve re-isolation at repeat ablation procedure
Description
total time of RF delivery required to re-isolate the reconnected pulmonary veins at a repeat ablation procedure
Time Frame
at repeat ablation procedure (6-12 months post-index ablation procedure)
Title
complications
Description
procedure-related complications
Time Frame
acute and subacute (intra-procedure, and during entire follow-up period)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Participant is undergoing de novo pulmonary vein isolation procedure. Participant is willing and able to give informed consent for participation in the study. Male or Female, ≥18 years of age. Exclusion Criteria: Previous percutaneous or open surgical procedure involving the left atrium Pregnancy (current or currently planning)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael A Jones, MBBS
Organizational Affiliation
Oxford University Hospitals NHS Trust
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Tim R Betts, MbCHb PhD
Organizational Affiliation
Oxford University Hospitals NHS Trust
Official's Role
Study Director
Facility Information:
Facility Name
John Radcliffe Hospital
City
Headington
State/Province
Oxfordshire
ZIP/Postal Code
Ox39DU
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation

We'll reach out to this number within 24 hrs